DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models

Journal Article · · Science Translational Medicine
ORCiD logo [1]; ORCiD logo [2];  [3];  [1]; ORCiD logo [1]; ORCiD logo [4];  [1];  [1]; ORCiD logo [5]; ORCiD logo [6];  [6];  [7]; ORCiD logo [4];  [2]; ORCiD logo [1]
  1. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
  2. Division of Thoracic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  3. Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  4. Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  5. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  6. Biogen, Cambridge, MA 02142, USA.
  7. Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Positron emission tomography with a probe targeting type I collagen enables detection, staging, and treatment response monitoring in lung fibrosis.

Sponsoring Organization:
USDOE
OSTI ID:
1477818
Alternate ID(s):
OSTI ID: 1536853
Journal Information:
Science Translational Medicine, Journal Name: Science Translational Medicine Journal Issue: 384 Vol. 9; ISSN 1946-6234
Publisher:
American Association for the Advancement of Science (AAAS)Copyright Statement
Country of Publication:
United States
Language:
English

References (49)

MMP expression and abnormal lung permeability are important determinants of outcome in IPF journal January 2009
Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis journal January 2008
Simple method of estimating severity of pulmonary fibrosis on a numerical scale. journal April 1988
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions journal August 2015
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy journal January 2001
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis journal May 2014
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials journal May 2011
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis journal May 2014
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality journal September 2001
Role of the Lysophospholipid Mediators Lysophosphatidic Acid and Sphingosine 1-Phosphate in Lung Fibrosis journal July 2012
Guidelines for reporting experiments involving animals: the ARRIVE guidelines: Guidelines for reporting experiments involving animals journal July 2010
Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis journal July 2001
AMIDE: A Free Software Tool for Multimodality Medical Image Analysis journal July 2003
Molecular Magnetic Resonance Imaging of Pulmonary Fibrosis in Mice journal December 2013
In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011 journal May 2016
Ly6C hi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis journal September 2011
Clinical applications of Gallium-68 journal June 2013
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes journal January 2016
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management journal March 2011
Idiopathic Pulmonary Fibrosis: Spectrum of High-Resolution CT Findings journal December 2005
Electron Microscopy of Collagen Fibril Structure In Vitro and In Vivo Including Three-Dimensional Reconstruction book January 2008
68Ga-DOTANOC PET/CT Allows Somatostatin Receptor Imaging in Idiopathic Pulmonary Fibrosis: Preliminary Results journal November 2010
3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model journal September 2015
PET/CT: Form and Function journal February 2007
Limiting TGF-β signaling to prevent fibrosis journal February 2015
Preclinical SPECT/CT Imaging of  v 6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis journal October 2013
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs journal June 2011
Collagen-Targeted MRI Contrast Agent for Molecular Imaging of Fibrosis journal November 2007
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study journal June 2015
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis journal January 1998
Development of a Multigram Asymmetric Synthesis of 2-( R )-2-(4,7,10-Tris tert -Butylcarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)-pentanedioic Acid, 1- tert -Butyl Ester, ( R )- tert -Bu 4 -DOTAGA(1) journal May 2009
The importance of correction for tissue fraction effects in lung PET: preliminary findings journal August 2011
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? journal January 2008
18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials journal November 2011
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients journal August 2013
Stretch-induced Activation of Transforming Growth Factor-β 1 in Pulmonary Fibrosis journal July 2016
Liquid chromatographic determination of hydroxyproline in tissue samples journal July 2003
Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation journal January 2008
Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models journal September 2012
Hydroxyproline: A Potential Biochemical Marker and Its Role in the Pathogenesis of Different Diseases journal July 2016
A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1 journal February 1999
The α v β 1 integrin plays a critical in vivo role in tissue fibrosis journal May 2015
Synthesis and characterization of a high-affinity  v 6-specific ligand for in vitro and in vivo applications journal May 2009
Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis journal September 2015
Mechanisms of fibrosis: therapeutic translation for fibrotic disease journal July 2012
Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury journal December 2010
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor journal May 2007
Molecular MRI of collagen to diagnose and stage liver fibrosis journal November 2013
Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging with Use of a Collagen-targeting Contrast Agent journal June 2008